Quick Takeaways
- K2 HealthVentures Equity Trust LLC filed SCHEDULE 13G for Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA).
- Disclosed ownership: 6.6%.
- Date of event: 09 May 2025.
K2 HealthVentures Equity Trust LLC - 09 May 2025 SCHEDULE 13G Report for Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA)
- Filing Manager
- K2 HealthVentures Equity Trust LLC
- Reporting Manager
- K2 HealthVentures Equity Trust LLC
- Symbol
- NMRA
- Shares outstanding
- 172,686,515 shares
- Disclosed Ownership
- 11,397,310 shares
- Ownership
- 6.6%
- Form type
- SCHEDULE 13G
- Filing time
- 11 Aug 2025, 16:55:43 UTC
- Date of event
- 09 May 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"K2 HealthVentures Equity Trust LLC disclosed 6.6% ownership in Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA) on 09 May 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 11 Aug 2025, 16:55.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| K2 HealthVentures Equity Trust LLC | 6.6% | 11,397,310 | 0 | 11,397,310 | /s/ Anup Arora | Anup Arora, Managing Member | |
| Parag Shah | 6.6% | 11,397,310 | 0 | 11,397,310 | /s/ Parag Shah | Parag Shah | |
| Anup Arora | 6.6% | 11,397,310 | 0 | 11,397,310 | /s/ Anup Arora | Anup Arora |